Atlantic Union Bankshares Corp Boosts Stock Position in Align Technology, Inc. $ALGN

Atlantic Union Bankshares Corp grew its holdings in shares of Align Technology, Inc. (NASDAQ:ALGN) by 4,675.0% in the 3rd quarter, HoldingsChannel reports. The firm owned 5,730 shares of the medical equipment provider’s stock after acquiring an additional 5,610 shares during the quarter. Atlantic Union Bankshares Corp’s holdings in Align Technology were worth $718,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently made changes to their positions in ALGN. Jones Financial Companies Lllp boosted its holdings in shares of Align Technology by 145.5% in the 3rd quarter. Jones Financial Companies Lllp now owns 1,733 shares of the medical equipment provider’s stock worth $219,000 after buying an additional 1,027 shares during the last quarter. National Pension Service bought a new stake in Align Technology in the third quarter worth about $308,000. AlphaQuest LLC purchased a new position in Align Technology in the third quarter valued at about $251,000. Arizona State Retirement System boosted its stake in Align Technology by 0.4% in the third quarter. Arizona State Retirement System now owns 20,387 shares of the medical equipment provider’s stock valued at $2,553,000 after acquiring an additional 79 shares during the last quarter. Finally, Impact Partnership Wealth LLC bought a new position in shares of Align Technology during the 3rd quarter valued at approximately $370,000. 88.43% of the stock is currently owned by institutional investors.

Align Technology Stock Up 2.7%

Shares of NASDAQ ALGN opened at $161.30 on Thursday. The stock’s 50-day simple moving average is $161.89 and its two-hundred day simple moving average is $148.59. Align Technology, Inc. has a twelve month low of $122.00 and a twelve month high of $232.20. The firm has a market capitalization of $11.57 billion, a P/E ratio of 31.26, a P/E/G ratio of 1.76 and a beta of 1.84.

Align Technology (NASDAQ:ALGN) last issued its quarterly earnings results on Wednesday, February 4th. The medical equipment provider reported $3.29 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.99 by $0.30. Align Technology had a return on equity of 13.96% and a net margin of 9.50%.The firm had revenue of $1.05 billion during the quarter, compared to the consensus estimate of $1.03 billion. During the same quarter last year, the company posted $2.44 EPS. The company’s revenue for the quarter was up 5.3% on a year-over-year basis. As a group, research analysts anticipate that Align Technology, Inc. will post 7.98 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research firms recently commented on ALGN. Barclays began coverage on shares of Align Technology in a report on Monday, December 8th. They issued an “equal weight” rating and a $170.00 price target on the stock. Wells Fargo & Company lowered their target price on Align Technology from $199.00 to $181.00 and set an “overweight” rating on the stock in a research note on Thursday, October 30th. Piper Sandler reiterated an “overweight” rating and set a $200.00 price target (up previously from $190.00) on shares of Align Technology in a research note on Thursday, October 30th. HSBC boosted their price objective on Align Technology from $140.00 to $150.00 in a research note on Friday, October 31st. Finally, Weiss Ratings upgraded shares of Align Technology from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday, January 16th. Six equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. According to MarketBeat, the stock has an average rating of “Hold” and an average target price of $176.82.

Key Stories Impacting Align Technology

Here are the key news stories impacting Align Technology this week:

• Positive Sentiment: Q4 results beat consensus — GAAP EPS of $3.29 vs. $2.99 expected and revenue of ~$1.048B vs. ~$1.03B expected, showing year-over-year improvement and better-than-forecast profitability. Align Technology (ALGN) Surpasses Q4 Earnings and Revenue Estimates
• Positive Sentiment: Management cited strong demand for dental products (Invisalign system and related digital solutions) as the driver of the beat, which supports revenue momentum going into the new quarter. Align Technology beats fourth-quarter results estimates on dental products demand
• Positive Sentiment: Full press release and reported metrics: total Q4 revenue +5.3% year-over-year and sequential growth; company provided supporting slide deck and call for more detail (useful for investors who want line-of-business and regional breakdowns). Align Technology Announces Fourth Quarter and Fiscal 2025 Financial Results
• Neutral Sentiment: Q1 guidance was reported roughly in line with analyst expectations — this tempers upside from the print (no major beat-and-raise) and means future stock moves will depend on execution and trends called out on the conference call. Align Technology beats fourth-quarter results estimates on dental products demand

Align Technology Profile

Align Technology, Inc (NASDAQ: ALGN) pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.

The company’s signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.